Status:
COMPLETED
OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Pituitary Adenoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to assess accurancy of OCT angiography as a pronostic marker for patients undergoing neurosurgery for compressiver macroadenoma as compared with visual acuity, visual field and...
Eligibility Criteria
Inclusion
- pituitary compressive adenoma (for experimental group)
- pituitary non compressive adenoma
Exclusion
- retinian disease
- amblyopia
- parkinson disease
- pregnant woman
Key Trial Info
Start Date :
November 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 22 2023
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT04074642
Start Date
November 14 2019
End Date
February 22 2023
Last Update
November 18 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de NICE
Nice, France, 06000
2
Hôpital Pasteur 2 - Service d'Ophtalmologie
Nice, France, 06001